These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26269406)

  • 1. PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
    Tensen CP
    J Invest Dermatol; 2015 Sep; 135(9):2153-2154. PubMed ID: 26269406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLCG1 mutations in cutaneous T-cell lymphomas.
    Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM; González-Vela C; Rubio-Camarillo M; Martín-Sánchez E; Pisano DG; Papadavid E; Papadaki T; Requena L; García-Marco JA; Méndez M; Provencio M; Hospital M; Suárez-Massa D; Postigo C; San Segundo D; López-Hoyos M; Ortiz-Romero PL; Piris MA; Sánchez-Beato M
    Blood; 2014 Mar; 123(13):2034-43. PubMed ID: 24497536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas.
    Caumont C; Gros A; Boucher C; Mélard P; Prochazkova-Carlotti M; Laharanne E; Pham-Ledard A; Vergier B; Chevret E; Beylot-Barry M; Merlio JP; Cappellen D
    J Invest Dermatol; 2015 Sep; 135(9):2334-2337. PubMed ID: 25910029
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.
    Patel VM; Flanagan CE; Martins M; Jones CL; Butler RM; Woollard WJ; Bakr FS; Yoxall A; Begum N; Katan M; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2020 Feb; 140(2):380-389.e4. PubMed ID: 31376383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
    Damsky WE; Choi J
    Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
    Whittaker S
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
    Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant phospholipase C gamma 1 activity promotes CTCL growth.
    Cancer Discov; 2014 Apr; 4(4):OF13. PubMed ID: 24706664
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
    Karenko L; Hahtola S; Päivinen S; Karhu R; Syrjä S; Kähkönen M; Nedoszytko B; Kytölä S; Zhou Y; Blazevic V; Pesonen M; Nevala H; Nupponen N; Sihto H; Krebs I; Poustka A; Roszkiewicz J; Saksela K; Peterson P; Visakorpi T; Ranki A
    Cancer Res; 2005 Sep; 65(18):8101-10. PubMed ID: 16166283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular advances in cutaneous T-cell lymphoma.
    Bastidas Torres AN; Najidh S; Tensen CP; Vermeer MH
    Semin Cutan Med Surg; 2018 Mar; 37(1):81-86. PubMed ID: 29719024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
    Manso R; Rodríguez-Pinilla SM; González-Rincón J; Gómez S; Monsalvo S; Llamas P; Rojo F; Pérez-Callejo D; Cereceda L; Limeres MA; Maeso C; Ferrando L; Pérez-Seoane C; Rodríguez G; Arrinda JM; García-Bragado F; Franco R; Rodriguez-Peralto JL; González-Carreró J; Martín-Dávila F; Piris MA; Sánchez-Beato M
    Haematologica; 2015 Jan; 100(1):e25-7. PubMed ID: 25304611
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis.
    Goeldel AL; Cornillet-Lefebvre P; Durlach A; Birembaut P; Bernard P; Nguyen P; Grange F
    Br J Dermatol; 2010 Apr; 162(4):822-9. PubMed ID: 19906072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.